Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of an Amylopectin Chromium Blend on Whole-Body Protein Kinetics and Glucose Control in Peri/Post-Menopausal Women

NCT07402382 is registered in ClinicalTrials.gov with Nutrition 21, Inc. as lead sponsor.

NCT NCT07402382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07402382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of an Amylopectin Chromium Blend on Whole-Body Protein Kinetics and Glucose Control in Peri/Post-Menopausal Women
Lead sponsor
Nutrition 21, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2025
Completion date
September 30, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glucose monitoring, continuous, peri-menopausal women, post-menopause, whole body protein metabolism